Cancer Cachexia and the Brain Stem | NEJM
The author describes the science behind a study of ponsegromab to treat cancer cachexia. Ponsegromab suppresses a pathway in neurons located in specific regions of the brain stem.
The author describes the science behind a study of ponsegromab to treat cancer cachexia. Ponsegromab suppresses a pathway in neurons located in specific regions of the brain stem.
A 37-year-old man was transferred to the hospital because of fever, myalgia, and hypoxemia. Evaluation revealed leukocytosis, acute kidney failure, and conjugated hyperbilirubinemia. A …
This volume explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It examines how trust and perceived expertise influence…
Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating Mycobacterium tuberculosis infection among contacts of persons with d…
These resources are for anyone shopping (or helping someone shop) for health coverage within the health insurance marketplaces created through the Affordable Care Act (also…
Booster doses of the original monovalent COVID-19 vaccine are associated with lower incidence of symptoms in health care personnel 6 weeks postinfection.
Recent legal and regulatory uncertainty has led to concerns about the long-term viability and efficacy of certain types of physician-led health care structures as an…
Illustrated Glossary from The New England Journal of Medicine
A 63-year-old man with a history of CABG presented with a 2-month history of angina during exertion of the left arm. Angiography revealed retrograde flow…
Click on the article title to read more.
Airway diseases are a heterogeneous group of disorders that impact airflow. Recent advances in the field are providing important insights into the management of these…